Form 4 for DERM Journey Medical Corp
Accepted 2026-04-24 17:27:06 ET · period of report 2026-04-22 · accession 0001104659-26-048731 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 17:27 | 2026-04-22 | DERM | Maraoui Claude | Pres, CEO, Dir | A - Grant | $0.00 | +49.3K | 2.44M | +2% | $0 |
| D | 2026-04-24 17:27 | 2026-04-22 | DERM | Maraoui Claude | Pres, CEO, Dir | A - Grant | $0.00 | +82.9K | 82.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2026-04-22 | A | A | 49,277 | $0.00 | 2,435,990 | D | — | — | (F1) On April 22, 2026, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on April 22, 2027, 16,426 shares on April 22, 2028 and 16,425 shares on April 22, 2029. (F2) Includes restricted stock units, which vest over various time periods. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | A | A | 82,915 | $0.00 | 82,915 | D | $5.04 · — to 2036-04-22 | 82,915 Common Stock, $0.0001 par value | (F3) On April 22, 2026, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on April 22, 2027, 27,638 shares on April 22, 2028 and 27,639 shares on April 22, 2029. |